Altre lingue Ziccum AB

Azioni

ZICC

SE0011415595

Tempo differito Nasdaq Stockholm Altri mercati azionari 13:49:33 17/05/2024			Variaz. 5gg	Var. 1 gen.
5,94 ^SEK	+0,34%		-7,48%	-22,45%

29/04	Ziccum AB (publ) riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
14/03	Il progetto mRNA/LNP inalabile di Ziccum AB (publ) conferma le eccellenti proprietà ottenute da LaminarPace	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Ziccum CEO Analyst video interview: Q1, 2024 highlights	06/05
Ziccum AB strengthens patent portfolio with three solid data PCT applications according to expanded IP strategy	30/04
Ziccum AB (publ) Interim report Q1 2024	29/04
Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Ziccum contracts RFR Solutions for GMP manufacturing in next phase of technology scale-out	26/04
Ziccum AB (publ) releases Annual Report 2023	15/04
Ziccum CEO to present at first annual event for Biopharma/Biotech disruptors hosted by major US bank in New York City	10/04
Ziccum strengthens and streamlines business and finance functions	03/04
Ziccum inhalable mRNA/LNP project confirms excellent properties obtained by LaminarPace	14/03
Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace	14/03
Ziccum reports significant progress in 3D-modelling project with model completion	01/03
Ziccum AB and project partner Zurich institute of Applied Sciences Updates LaminarPace Simulation Project Progress and Findings	01/03
Ziccum announces last day of trading in BTU	26/02
Ziccum announces outcome in rights issue	16/02
Ziccums CEO Ann Gidner in Fireside Chat on mRNA development hosted by US Force Family Office	12/02
Last day for trading in unit rights in Ziccum	09/02
Ziccum's Board of Directors and Management Group use all their Unit Rights in the ongoing new share issue.	08/02
Ziccum CEO video interview: mRNA in focus	05/02
Join Ziccum CEO Ann Gidner for ‘Invest Live’, a live digital presentation and Q&A, Tues Feb 6th	03/02
Ziccum has proven excellent mRNA activity in animal study with LaminarPace material	31/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ziccum AB

Azioni

ZICC

SE0011415595

Altre lingue

Filtri